What TriSalus Life Sciences Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 12 |
| Sells | 3 | 18 |
| Total trades | 4 | 55 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 2,219,760 |
| Disposed | 3,630 | 52,503 |
| Net activity | −3,630 | +2,167,257 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Marshak Richard | Chief Commercial Officer | Oct 05 | Sale for tax withholding · S | −325 | $4.39 | −$1.43K | 127,994 |
| Cox Bryan F. | Chief of Research | Oct 05 | Sale for tax withholding · S | −296 | $4.39 | −$1.3K | 162,805 |
| Szela Mary T | CEO and President | Oct 05 | Withheld — tax / exercise cost · F | −2,693 | $4.38 | −$11.8K | 1,074,990 |
| Stevens Jennifer | Chief Regulatory Officer | Oct 05 | Sale for tax withholding · S | −316 | $4.39 | −$1.39K | 123,794 |
| Patience David | Chief Financial Officer | Jul 01 | Withheld — tax / exercise cost · F | −14,650 | $4.46 | −$65.3K | 261,107 |
| Szela Mary T | CEO and President | Jun 30 | Grant / award · A | +3,990 | $3.87 | +$15.4K | 1,077,683 |
| Marshak Richard | Chief Commercial Officer | Jun 30 | Grant / award · A | +561 | $3.87 | +$2.17K | 128,319 |
| Marshall Richard Henry | Chief Medical Officer | Jun 29 | Grant / award · A | +60,000 | — | — | 90,000 |
| Patience David | Chief Financial Officer | May 15 | Open-market buy · P | +7,100 | $2.43 | +$17.3K | 275,757 |
| Wahlstrom Mats | Director | May 15 | Open-market buy · P | +60,000 | $2.53 | +$152K | 147,555 |
| Szela Mary T | CEO and President | May 15 | Open-market buy · P | +39,682 | $2.59 | +$103K | 1,065,215 |
| Marshak Richard | Chief Commercial Officer | May 15 | Sale for tax withholding · S | −543 | $2.67 | −$1.45K | 125,101 |
| Stansky Michael P | Director | May 15 | Open-market buy · P | +200,000 | $2.50 | +$500K | 399,698 |
| Stansky Michael P | Director | May 15 | Open-market buy · P | +410,000 | $2.50 | +$1.03M | 1,240,722 |
| Gordon Gary B. | Director | May 15 | Open-market buy · P | +10,000 | $2.46 | +$24.6K | 72,510 |
| Stansky Michael P | Director | May 14 | Grant / award · A | +20,089 | — | — | 830,722 |
| Stansky Michael P | Director | May 14 | Grant / award · A | +23,501 | — | — | 810,633 |
| Valle William | Director | May 14 | Grant / award · A | +24,553 | — | — | 83,241 |
| Valle William | Director | May 14 | Grant / award · A | +28,201 | — | — | 58,688 |
| Matlin David J | Director | May 14 | Grant / award · A | +23,065 | — | — | 1,323,210 |
Loading...
